BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3136958)

  • 1. Interleukin 2 receptor in patients with localized and systemic parasitic diseases.
    Josimovic-Alasevic O; Feldmeier H; Zwingenberger K; Harms G; Hahn H; Shrisuphanunt M; Diamantstein T
    Clin Exp Immunol; 1988 May; 72(2):249-54. PubMed ID: 3136958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble interleukin 2 receptors in patients with malignant lymphoma.
    Harrington DS; Patil K; Lai PK; Yasuda NN; Armitage JO; Ip SH; Weisenburger DD; Linder J; Purtilo DT
    Arch Pathol Lab Med; 1988 Jun; 112(6):597-601. PubMed ID: 2837161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
    Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.
    Kitaoka S; Shiota G; Kawasaki H
    Hepatogastroenterology; 2003; 50(53):1569-74. PubMed ID: 14571788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.
    Rubin LA; Kurman CC; Fritz ME; Biddison WE; Boutin B; Yarchoan R; Nelson DL
    J Immunol; 1985 Nov; 135(5):3172-7. PubMed ID: 3930598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous expression of the interleukin 2 receptor gene and presence of functional interleukin 2 receptors on T lymphocytes in the blood of individuals with active pulmonary sarcoidosis.
    Konishi K; Moller DR; Saltini C; Kirby M; Crystal RG
    J Clin Invest; 1988 Sep; 82(3):775-81. PubMed ID: 3138285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of interleukin-2 receptor in schistosomiasis mansoni and its analogous changes in collagen diseases and schistosomal arthropathy.
    Khalil HM; el Missiry AG; Fahmy HM; Khalil NM; Nadia ; Sabry M; Abdel Atty HE; Tamara FA; Amer N; el Baz HG
    J Egypt Soc Parasitol; 1995 Aug; 25(2):289-302. PubMed ID: 7665927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin (IL)-4, IL-10, IL-18 and IFN-gamma cytokines pattern in patients with combined hepatitis C virus and Schistosoma mansoni infections.
    El-Kady IM; Lotfy M; Badra G; El-Masry S; Waked I
    Scand J Immunol; 2005 Jan; 61(1):87-91. PubMed ID: 15644127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depressed interleukin 2 receptor expression in acquired immune deficiency and lymphadenopathy syndromes.
    Prince HE; Kermani-Arab V; Fahey JL
    J Immunol; 1984 Sep; 133(3):1313-7. PubMed ID: 6235286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive secretion of soluble interleukin-2 receptor by human T cell lymphoma xenografted into SCID mice. Correlation of tumor volume with concentration of tumor-derived soluble interleukin-2 receptor in body fluids of the host mice.
    Wasik MA; Sioutos N; Tuttle M; Butmarc JR; Kaplan WD; Kadin ME
    Am J Pathol; 1994 May; 144(5):1089-97. PubMed ID: 8178932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the levels of serum-soluble interleukin-2 receptor after surgical stress.
    Murakami S; Sakata H; Tsuji Y; Okubo K; Takahashi T; Kikuchi M; Hirayama R
    Surg Today; 2003; 33(8):565-70. PubMed ID: 12884092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of IL 2 and IFN-gamma by T cells from malaria patients in response to Plasmodium falciparum or erythrocyte antigens in vitro.
    Troye-Blomberg M; Andersson G; Stoczkowska M; Shabo R; Romero P; Patarroyo ME; Wigzell H; Perlmann P
    J Immunol; 1985 Nov; 135(5):3498-504. PubMed ID: 3930605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased levels of soluble interleukin-4 receptor in the sera of patients with visceral leishmaniasis.
    Sang DK; Ouma JH; John CC; Whalen CC; King CL; Mahmoud AA; Heinzel FP
    J Infect Dis; 1999 Mar; 179(3):743-6. PubMed ID: 9952391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized scleroderma.
    Ihn H; Sato S; Fujimoto M; Kikuchi K; Takehara K
    Br J Dermatol; 1996 May; 134(5):843-7. PubMed ID: 8736323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum interleukin 1 receptors and interleukin 1B in patients with Behçet's disease: correlations with disease activity and severity.
    Yosipovitch G; Shohat B; Bshara J; Wysenbeek A; Weinberger A
    Isr J Med Sci; 1995 Jun; 31(6):345-8. PubMed ID: 7607852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring soluble interleukin-2 receptor levels in related and unrelated donor allogenic bone marrow transplantation.
    Foley R; Couban S; Walker I; Greene K; Chen CS; Messner H; Gauldie J
    Bone Marrow Transplant; 1998 Apr; 21(8):769-73. PubMed ID: 9603399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helminthic infection down-regulates type 1 immune responses in human T cell lymphotropic virus type 1 (HTLV-1) carriers and is more prevalent in HTLV-1 carriers than in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Porto AF; Santos SB; Muniz AL; Basilio V; Rodrigues W; Neva FA; Dutra WO; Gollob KJ; Jacobson S; Carvalho EM
    J Infect Dis; 2005 Feb; 191(4):612-8. PubMed ID: 15655786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating soluble interleukin-2 receptor alpha and beta chain in inflammatory bowel disease.
    Nielsen OH; Ciardelli T; Wu Z; Langholz E; Kirman I
    Am J Gastroenterol; 1995 Aug; 90(8):1301-6. PubMed ID: 7639234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of Trypanosoma cruzi-induced immunosuppression. Altered expression by activated human lymphocytes of molecules which regulate antigen recognition and progression through the cell cycle.
    Kierszenbaum F; Moretti E; Sztein MB
    Biol Res; 1993; 26(1-2):197-207. PubMed ID: 7670532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble interleukin-2 receptors in sera of children with primary malignant neoplasms.
    Bodey B; Psenko V; Lipsey AL; Kaiser HE
    Anticancer Res; 1996; 16(1):219-24. PubMed ID: 8615612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.